| Authors: |
Kuhn BJ; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA. Electronic address: bkuhn@cellphire.com., Swanson A; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Cherupalla AS; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Booth L; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Dickerson WM; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Fitzpatrick GM; Product Development, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Alexander WA; Medical Science and Clinical Development, Cellphire Therapeutics, Inc, Rockville, Maryland, USA., Moskowitz KA; Department of Discovery Research, Cellphire Therapeutics, Inc, Rockville, Maryland, USA. |